Chinese Hamster Ovary Cells (CHO) Market | Value and Size Expected to Reach USD 688.95 Million at CAGR of 11.90%| Forecast Period 2023-2030
Data Bridge Market Research
analyses that the Chinese Hamster Ovary Cells (CHO) market, valued at USD 280.25 Million in 2022, will reach USD
688.95 Million by 2030
%20Market.jpg)
Key Pointers Covered
in Chinese Hamster Ovary Cells (CHO) Market Industry Trends and Forecast to 2030
·
Market
Size
·
Market
New Sales Volumes
·
Market
Replacement Sales Volumes
·
Market
Installed Base
·
Market
By Brands
·
Market
Procedure Volumes
·
Market
Product Price Analysis
·
Market
Regulatory Framework and Changes
·
Market
Shares in Different Regions
·
Recent
Developments for Market Competitors
·
Market
Upcoming Applications
·
Market
Innovators Study
Get sample copy of
the report:
Benefits of
Considering this Report:
·
This
report is compiled using a vigorous and thorough research methodology. Data
Bridge Market Research is also known for its data accuracy and granular market
reports.
·
A
complete picture of the competitive scenario of Chinese Hamster Ovary Cells
(CHO) Market is depicted by this report.
·
The report
consists of a vast amount of data about the recent product and technological
developments in the markets.
·
The
insights in the report are easy to understand and include a graphical
representation of the numbers in the form of histograms, bar graphs, pie
charts, etc.
Chinese Hamster
Ovary Cells (CHO) Market Scope and Market Size
The Global Chinese Hamster Ovary cells (CHO)
market is segmented on the
basis of product, system, application, and end- users. The growth amongst these
segments will help you analyze meagre growth segments in the industries and
provide the users with a valuable market overview and market insights to help
them make strategic decisions for identifying core market applications.
Product
·
CHO-K1
·
CHO-DXB1
·
CHO-S
·
CHO-
DG44
·
Others
System
·
Antibiotic
Selection System
·
Metabolic
Selection System
Application
·
Monoclonal
antibodies
·
Cytokines
·
Enzymes
·
Fc-
Fusion Protein
·
Hormones
·
Clotting
Factors
·
Others
End-
Users
·
Biopharmaceutical
Companies
·
Biotech
Companies
·
Academic
Institutes and Research
·
Clinical
Research Organizations
·
Clinical
Development and Manufacturing Organization
·
Others
Get Full Access of Report
https://www.databridgemarketresearch.com/reports/global-chinese-hamster-ovary-cells-cho-market
Some of the key questions answered in this
report:
·
How has the Chinese Hamster Ovary Cells (CHO)
Market performed so far and how will it perform in the coming years?
·
What are the key regional markets?
·
What is the breakup of the market based on the
procedure?
·
What is the breakup of the market based on the injury
location?
·
What is the breakup of the market based on the
end user?
·
What are the various stages in the value chain
of the industry?
·
What are the key driving factors and challenges
in the industry?
·
What is the structure of the Chinese Hamster
Ovary Cells (CHO) Market and who are the key players?
·
What is the degree of competition in the
industry?
Market Analysis and
Insights: Chinese Hamster Ovary Cells (CHO) Market
· The global Chinese hamster ovary cells (CHO) market is
estimated to increase rapidly over the forecast period. Chinese Hamster Ovary
(CHO) cells have emerged as the gold standard in biologics development. They
are the optimal cell line for producing various proteins due to their unique
combination of excellent quality properties. CHO cells are a robust bioprocess
tool because they are easy to grow in large-scale cell culture under controlled
circumstances and allow human biosimilar post-translational alterations. Hence,
this will lead to a high demand for Chinese Hamster Ovary (CHO) cells.
· CHO cells are a cell line produced from the ovaries of
the Chinese hamster. They are the most commonly employed mammalian hosts in
biological and medical research, especially for producing human therapeutic
proteins. Around 70% of recombinant therapeutic proteins are generated in CHO
cell cultures. Human-compatible post-translational changes can also be
performed on CHO cells, making them excellent for medicinal and pharmaceutical
applications such as protein production. CHO cells are known for their ability to
produce complex recombinant proteins, making them a valuable tool in the
biopharmaceutical industry.
· The rising use of genetics study will further
accelerate the demand for the market. Because of the vigorous proliferation as
adherent cells or in suspension, the CHO cell has become a standard source of
cells. They're also adaptable to genetic changes. Hence, used for genetic
studies.
· The increasing demand for biopharmaceuticals,
including therapeutic proteins, monoclonal antibodies, and vaccines, is a major
driver for the CHO cell market. CHO cells are the preferred host cells for
producing these complex biologics due to their ability to express and secrete
high yields of recombinant proteins.
Chinese Hamster
Ovary Cells (CHO) Market Country Level Analysis
·
U.S., Canada and
Mexico in [North America]
·
Germany, France,
U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, [Rest of
Europe]
·
China, Japan,
India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia,
Philippines, [Rest of Asia-Pacific (APAC)]
·
Saudi Arabia,
U.A.E, South Africa, Egypt, Israel, [Rest of Middle East and Africa (MEA)]
·
Brazil, Argentina
and [Rest of South America]
Chinese Hamster
Ovary Cells (CHO) Market Share Analysis
The Chinese Hamster Ovary
cells (CHO) market competitive landscape provides details by competitor.
Details included are company overview, company financials, revenue generated,
market potential, investment in research and development, new market initiatives,
global presence, production sites and facilities, production capacities,
company strengths and weaknesses, product launch, product width and breadth,
application dominance. The above data points provided are only related to the
companies' focus related to market.
Key player Chinese
Hamster Ovary Cells (CHO) Market
·
Aragen
Life Sciences Pvt. Ltd. (India)
·
Selexis
SA (Switzerland)
·
Merck
KGaA (Germany)
·
CELONIC
Group (Switzerland)
·
Promega
Corporation (U.S.)
·
JSR
Life Sciences, LLC (U.S.)
·
trenzyme
GmbH (Germany)
·
Thermo
Fisher Scientific Inc. (U.S.)
·
WuXi
Biologics (China)
·
Cygnus
Technologies. (U.S.)
·
ProBioGen
AG (German)
MAJOR TOC OF THE REPORT
·
Chapter
One: Introduction
·
Chapter
Two: Market Segmentation
·
Chapter
Three: Market Overview
·
Chapter
Four: Executive Summary
·
Chapter
Five: Premium Insights
·
Chapter
Six: Chinese Hamster Ovary Cells (CHO) Market Share by Product & Procedure
type
Get TOC Details:
https://www.databridgemarketresearch.com/toc/?dbmr=global-chinese-hamster-ovary-cells-cho-market
Top Trending Reports:
·
https://www.databridgemarketresearch.com/reports/global-telemental-health-market
·
https://www.databridgemarketresearch.com/reports/global-chinese-hamster-ovary-cells-cho-market
·
https://www.databridgemarketresearch.com/reports/global-ice-maker-market
·
https://www.databridgemarketresearch.com/reports/gcc-cyber-security-market
·
https://www.databridgemarketresearch.com/reports/global-thermal-paper-market
About Us:
Data Bridge
Market Research set forth
itself as an unconventional and neoteric Market research and consulting firm
with unparalleled level of resilience and integrated approaches. We are
determined to unearth the best market opportunities and foster efficient information
for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Comments
Post a Comment